ALGS Competitors & Alternatives
Compare Aligos Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALGS
Main Stock$2.02
Tradestie Score
39
Market Cap
$71.53M
Revenue Growth
27.8%
Analyst Upside
+1725.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.01
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.83
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$32.02
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$32.05
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.56
|
$97.42M | - | 50 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.05
|
$96.93M | - | 42 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 41 | Compare |
|
PMVP
PMV Pharmaceuticals, Inc
|
$1.24
|
$72.07M | - | 45 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.20
|
$67.94M | - | 46 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$4.09
|
$25.84M | - | 28 | Compare |
More ALGS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry